GP facilitators and HIV infection. GPs should be involved early

PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors: A propensity-score matched analysis.

Journal of neuroendocrinology·2025

Self-monitoring of blood pressure following a stroke or transient ischaemic attack (TASMIN5S): a randomised controlled trial.

BMC cardiovascular disorders·2024

Understanding primary care transformation and implications for ageing populations and health inequalities: a systematic scoping review of new models of primary health care in OECD countries and China.

BMC medicine·2023

Closing the UK care home data gap - methodological challenges and solutions.

International journal of population data science·2021

Positive Development and Changes in Self-Rated Health Among Young Sexual Minority Males: The P18 Cohort Study.

Behavioral medicine (Washington, D.C.)·2019

A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.

Journal of neurology·2017

Head positioning after endovascular therapy for acute stroke due to large vessel occlusion (HeadSOAR): multicentre randomised controlled trial.

BMJ (Clinical research ed.)·2026

Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial.

BMJ (Clinical research ed.)·2026

Opioid prescribing after Joint Commission hospital accreditation inspections: quasi-experimental analysis.

BMJ (Clinical research ed.)·2026

Comparative Risk of Respiratory Virus Infections Among Patients with Asthma Treated with Biologic Therapies.

QJM : monthly journal of the Association of Physicians·2026

Biomarker-Guided Management in Vitreoretinal Diseases: Integrating Imaging, Pharmacotherapy, and Surgical Decision-Making-A Narrative Review.

Retina (Philadelphia, Pa.)·2026

Week 96 resistance analysis in participants receiving bictegravir/lenacapavir in the phase 2 ARTISTRY-1 study.

Antiviral therapy·2026

Industry updates in advanced therapy medicinal products and regenerative medicine - July 2026.

Regenerative medicine·2026

In Regulatory First, Myeloma Drug Approved Based on MRD Negativity.

Cancer discovery·2026

Structure and allostery in major facilitator superfamily symport mechanisms.

Acta crystallographica. Section D, Structural biology·2026

Related Experiment Videos

GP facilitators and HIV infection. GPs should be involved early

Related Concept Videos

PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors: A propensity-score matched analysis.

Self-monitoring of blood pressure following a stroke or transient ischaemic attack (TASMIN5S): a randomised controlled trial.

Understanding primary care transformation and implications for ageing populations and health inequalities: a systematic scoping review of new models of primary health care in OECD countries and China.

Closing the UK care home data gap - methodological challenges and solutions.

Positive Development and Changes in Self-Rated Health Among Young Sexual Minority Males: The P18 Cohort Study.

A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.

Head positioning after endovascular therapy for acute stroke due to large vessel occlusion (HeadSOAR): multicentre randomised controlled trial.

Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial.

Opioid prescribing after Joint Commission hospital accreditation inspections: quasi-experimental analysis.

Comparative Risk of Respiratory Virus Infections Among Patients with Asthma Treated with Biologic Therapies.

Biomarker-Guided Management in Vitreoretinal Diseases: Integrating Imaging, Pharmacotherapy, and Surgical Decision-Making-A Narrative Review.

Week 96 resistance analysis in participants receiving bictegravir/lenacapavir in the phase 2 ARTISTRY-1 study.

Industry updates in advanced therapy medicinal products and regenerative medicine - July 2026.

In Regulatory First, Myeloma Drug Approved Based on MRD Negativity.

Structure and allostery in major facilitator superfamily symport mechanisms.

Related Experiment Videos

GP facilitators and HIV infection. GPs should be involved early

Related Concept Videos

Related Articles